Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dietary supplements

Executive Summary

Could not be regulated by FDA as drugs solely on the basis of their potency or health claims, under legislation (HR 5746) introduced by Rep. Richardson (D-N.M.) on July 31. He describes the bill as a companion measure to Sen. Hatch's (R-Utah) S 2835 ("The Pink Sheet" June 29, T&G-12). Richardson also added an amendment to the FDA enforcement bill stating that the bill does not alter the law governing FDA's regulation of vitamins and minerals ("The Pink Sheet" July 13, T&G-4). In a July 31 floor statement, Richardson said "nearly every member" of Congress has received mail from constituents concerned about access to supplements.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel